Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,602 | -3,603 | -4,127 | -3,465 | -2,861 |
| Accounts receivable | -13 | 90 | N/A | N/A | N/A |
| Other Working Capital | 838 | 408 | 63 | -20 | 362 |
| Other Operating Activity | 5,204 | -4,491 | 637 | 612 | 569 |
| Operating Cash Flow | $-1,573 | $-7,596 | $-3,427 | $-2,873 | $-1,930 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,101 | 11,645 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -1,104 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -119 | 0 | 0 |
| Financing Cash Flow | $3,101 | $10,541 | $-119 | $N/A | $N/A |
| Beginning Cash Position | 6,708 | 3,763 | 3,763 | 3,763 | 3,763 |
| End Cash Position | 8,236 | 6,708 | 217 | 890 | 1,833 |
| Net Cash Flow | $1,528 | $2,945 | $-3,546 | $-2,873 | $-1,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,573 | -7,596 | -3,427 | -2,873 | -1,930 |
| Free Cash Flow | -1,573 | -7,596 | -3,427 | -2,873 | -1,930 |